CD20 Nb TRNT: targeted radionuclide therapy of non-hodgkin-lymphoma with anti-CD20 nanobodies

Nick Devoogdt (Promotor)
Matthias D'Huyvetter (Promotor)
Jan Tavernier (Co-promotor)

Ondersteunende Klinische wetenschappen

Scriptie/Masterproef: Doctoral Thesis

Datum prijs	24 mei 2019
Originele taal	English
Prijsuitreikende instantie	Vrije Universiteit Brussel

Citeer dit

Gerelateerde inhoud

projecten
SRP-Onderzoekszwaartepunt: Exploiting Peptides: Protein Binders, Modulators and Inhibitors for Imaging and Therapy [Exploit-PeptIT]
Project: Fundamenteel

'